MDxHealth SA
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -77.3% | +0.0% | -1,647.1% | – | |
| – | +84.8% | -44.9% | +94.6% | -41.9% | +102.1% | -48.2% | +101.7% | -50.3% | +107.5% | +0.0% | -48.8% | – | |
| – | +116.2% | -56.6% | +313.1% | -47.4% | +182.5% | -62.1% | +247.8% | -67.1% | -404.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +0.0% | -156.6% | – | |
| – | +114.8% | -59.5% | +130.0% | -88.0% | +91.4% | +18.4% | -23.5% | -27.7% | -79.5% | +0.0% | -27.8% | – | |
| – | +154.0% | -44.6% | +125.6% | -99.1% | +1,761.5% | – | -150,784.6% | -96.0% | – | +0.0% | -527.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -91.5% | – | -102.9% | -20.6% | +39.8% | – | -103.7% | – | |
| – | +101.2% | -61.6% | – | +230.3% | +2.6% | -37.6% | -154.4% | -85.6% | +206.4% | +0.0% | +102.6% | – | |
| – | – | – | – | +307.7% | -108.9% | – | -274.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -76.8% | +0.0% | -1,917.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.